SCHEMBL8384274

SCHEMBL8384274

NS(=O)(=O)c1ccc(C2=C(c3ccc(O)cc3)CC3(CC3)C2)cc1

nearest known ligand 0.72

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 18/20 0.72
PTGS1 P23219 17/20 0.72
CA12 O43570 2/20 0.58
CA2 P00918 2/20 0.58
CA9 Q16790 2/20 0.58
CA1 P00915 1/20 0.58
CA7 P43166 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8386156 0.94 PTGS2 (0.69) PTGS2PTGS1CA12CA2CA9
SCHEMBL8388648 0.94 PTGS2 (0.74) PTGS2PTGS1CA12CA2CA9
SCHEMBL8386271 0.85 PTGS2 (0.74) PTGS2PTGS1CA12CA2CA9
SCHEMBL8383901 0.84 PTGS2 (0.74) PTGS2PTGS1
SCHEMBL8387288 0.84 PTGS2 (0.72) PTGS2PTGS1CA12CA2CA9
SCHEMBL8385148 0.84 PTGS2 (0.72) PTGS2PTGS1CA12CA2CA9
SCHEMBL213644 0.84 PTGS2 (1.00) PTGS2PTGS1
SCHEMBL8384214 0.84 PTGS2 (1.00) PTGS2PTGS1CA12CA2CA9
SCHEMBL8384371 0.84 PTGS2 (0.74) PTGS2PTGS1CA12CA2CA9
SCHEMBL8387685 0.84 PTGS2 (0.72) PTGS2PTGS1CA12CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0743938-B1 SUBSTITUTED SPIRO COMPOUNDS FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 1999-04-21 EP disclosed
EP-0743938-A1 SUBSTITUTED SPIRO COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-11-27 EP disclosed
WO-1995021817-A1 SUBSTITUTED SPIRO COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-08-17 WO disclosed
US-5393790-A Diphenyl- or phenyl/pyridyl-substituted spiroheptenes, -octenes,-nonenes or -decenes; cyclooxygenase II inhibitors; side effect reduction; antipyretics; antiarthritic agents G.D. SEARLE & CO. (US) 1995-02-28 US disclosed